SUBSCRIBE
SUBSCRIBE

TG Therapeutics, Inc.

NEWS
Pharm Country
TG Therapeutics Announces Data Presentations from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis to be Presented at 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
September 29, 2021
 · 
9 min read
BioMidwest
Clinical Catch-Up: September 20-24
September 24, 2021
 · 
12 min read
 · 
Mark Terry
Pharm Country
TG Therapeutics Announces Publication of Results from an Integrated Safety Analysis of UKONIQ® (umbralisib) in Blood Advances
September 23, 2021
 · 
11 min read
Pharm Country
TG Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare ConferenceFireside chat scheduled for 10:40 AM ET on Monday, September 27, 2021
September 23, 2021
 · 
1 min read
Pharm Country
TG Therapeutics Announces Combination Data Presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
September 20, 2021
 · 
17 min read
Pharm Country
TG Therapeutics Recaps Schedule of Upcoming Data Presentations at the XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
September 13, 2021
 · 
14 min read
Pharm Country
TG Therapeutics to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceFireside chat available for on demand download at 7:00 AM ET on Monday, September 13, 2021
September 9, 2021
 · 
1 min read
Pharm Country
TG Therapeutics Announces Data Presentations at the Upcoming XIX International Workshop on Chronic Lymphocytic Leukemia (iwCLL)
August 30, 2021
 · 
5 min read
Business
TG Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
August 2, 2021
 · 
12 min read
Business
TG Therapeutics to Host Conference Call on Second Quarter 2021 Financial Results and Business UpdateConference call to be held Monday, August 2, 2021 at 8:30 AM ET
July 28, 2021
 · 
1 min read
Pharm Country
TG Therapeutics to Participate in the Ladenburg Thalmann 2021 Healthcare ConferenceFireside chat scheduled for Wednesday, July 14, 2021 at 12:30 PM ET
July 9, 2021
 · 
1 min read
Business
TG Therapeutics Mourns the Loss of Board Member, William J. Kennedy, PhD
June 29, 2021
 · 
2 min read
Drug Development
TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of Ublituximab in Multiple Sclerosis at 7th Congress of the European Academy of Neurology
June 18, 2021
 · 
9 min read
Drug Development
TG Therapeutics Announces Preclinical and Clinical Data Evaluating TG-1701 at the 16th International Congress on Malignant Lymphoma
June 18, 2021
 · 
6 min read
Drug Development
TG Therapeutics Announces Data from a Phase 1 Study Evaluating TG-1701 as a Monotherapy and as a Triple Combination with Ublituximab and UKONIQ® at the 2021 European Hematology Association Virtual Congress
June 11, 2021
 · 
10 min read
Pharm Country
TG Therapeutics Announces Data Presentations at the Upcoming 16th International Congress on Malignant Lymphoma
June 9, 2021
 · 
4 min read
Load More
AWARDS
  • 2026 - Best Places to Work - Badge (1).png
JOBS